If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picks3i Group Regulatory News (III)

Share Price Information for 3i Group (III)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,919.00
Bid: 2,919.00
Ask: 2,921.00
Change: 68.00 (2.39%)
Spread: 2.00 (0.069%)
Open: 2,853.00
High: 2,924.00
Low: 2,847.00
Prev. Close: 2,851.00
III Live PriceLast checked at -
3i Group is an Investment Trust

To provide its shareholders with quoted access to private equity and infrastructure returns, its main focus is on making quoted and unquoted equity and/ or debt investments in businesses and funds in Europe, Asia and the Americas.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Action Capital Markets Seminar & portfolio update

21 Mar 2024 07:00

RNS Number : 7017H
3i Group PLC
21 March 2024
 

 

21 March 2024

 

3i Group plc

Action Capital Markets Seminar and portfolio update

 

3i Group plc ("3i", or "the Group") will be holding a capital markets seminar this morning, involving presentations from the management team of Action, our largest portfolio company. The seminar will include a presentation on Action's results and strategy, as well as a separate presentation focused on Action's sustainability programme. A live webcast of the seminar will take place at 10:00 (UK time), with the sustainability session starting at 12:30 after a short break, and expected to end by 13:15. To register for the webcast, please visit https://www.3i.com/investor-relations. An on-demand webcast of the seminar will also be available by the end of the day.

 

As disclosed in our Q3 performance update, in its 2023 financial year Action generated net sales of ?11,324 million and operating EBITDA of ?1,615 million, 28% and 34% respectively higher than in 2022. Like-for-like sales growth was 16.7% and the business added 303 stores in the year. Operating leverage and good cost discipline were the main drivers behind the increased EBITDA margin of 14.3%.

 

Action has seen a strong start to 2024 across all its geographies. In the period to the end of week 11, net sales were ?2.5 billion, 21% ahead of the same period in 2023. Like-for-like sales growth in the first 11 weeks of the year (which, compared to the same period last year, had one fewer trading day) was 9.6%, with growth in transactions accounting for over 100% of the strong performance. Cash and cash equivalents as at 17 March 2024 was ?1,077 million. The business has added 32 stores in the year to date, including Action's first two stores in Portugal. Action is planning to make another dividend payment to shareholders in the last week of March. More details on Action's performance will be available in the presentation.

 

We have also recently completed our semi-annual portfolio company review meetings. The rest of the 3i portfolio continues to demonstrate overall resilience with the majority of companies showing good momentum into 2024. Our full year results will be published in May.

 

- Ends -

 

For further information, contact:

 

3i Group plc

 

Silvia Santoro

Investor enquiries

 

Kathryn van der Kroft

Media enquiries

 

 

 

Tel: +44 20 7975 3258

Email: silvia.santoro@3i.com

 

Tel: +44 20 7975 3021

Email: kathryn.vanderkroft@3i.com

 

Notes to editors:

 

About 3i Group

3i is a leading international investment manager focused on mid-market Private Equity and Infrastructure. Our core investment markets are northern Europe and North America.

 

For further information, please visit: www.3i.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCURVURSNUOUUR
Date   Source Headline
31st Jan 20184:16 pmRNSDirector/PDMR Shareholding
2nd Jan 20184:15 pmRNSPortfolio Update
19th Dec 20173:18 pmRNSTotal Voting Rights
19th Dec 20173:15 pmRNSDirector/PDMR Shareholding
12th Dec 20173:05 pmRNSBlock listing Interim Review
6th Dec 201711:13 amRNSDirector/PDMR Shareholding
5th Dec 201712:00 pmRNSDirector/PDMR Shareholding
4th Dec 201710:32 amRNSDirector Declaration
30th Nov 20173:29 pmRNSTotal Voting Rights
30th Nov 20173:28 pmRNSDirector/PDMR Shareholding
16th Nov 201712:19 pmRNSDoc re. Half Yearly Report 2017
16th Nov 20177:00 amRNS3i Group Half-year results to 30 September 2017
31st Oct 20173:54 pmRNSDirector/PDMR Shareholding
31st Oct 20173:53 pmRNSTotal Voting Rights
3rd Oct 201712:37 pmRNSPortfolio Update
29th Sep 20173:51 pmRNSTotal Voting Rights
29th Sep 20173:50 pmRNSDirector/PDMR Shareholding
18th Sep 20178:30 amRNSPrivate Equity Capital Markets Seminar
31st Aug 20173:48 pmRNSTotal Voting Rights
31st Aug 20173:46 pmRNSDirector/PDMR Shareholding
31st Jul 20174:41 pmRNSTotal Voting Rights
31st Jul 20174:36 pmRNSDirector/PDMR Shareholding
28th Jul 20174:12 pmRNSDirector/PDMR Shareholding
26th Jul 20173:14 pmRNSDirector/PDMR Shareholding
26th Jul 20177:00 amRNSQ1 Performance update
6th Jul 20173:24 pmRNSPortfolio Update
30th Jun 20174:28 pmRNSDirector/PDMR Shareholding
30th Jun 20173:18 pmRNSTotal Voting Rights
30th Jun 20173:17 pmRNSDirector/PDMR Shareholding
29th Jun 20172:54 pmRNSResult of AGM
29th Jun 20172:35 pmRNSDoc re. AGM Resolutions
29th Jun 20172:25 pmRNSDirector/PDMR Shareholding
19th Jun 20174:19 pmRNSDTR 6.3.5
13th Jun 201711:26 amRNSDirector/PDMR Shareholding
12th Jun 20174:48 pmRNSBlock listing Interim Review
2nd Jun 201711:16 amRNSDirector/PDMR Shareholding
31st May 20174:25 pmRNSTotal Voting Rights
31st May 20174:21 pmRNSDirector/PDMR Shareholding
31st May 201710:12 amRNSDoc re. 2017 Annual Report and Accounts
30th May 20178:30 amRNSPrivate Equity Capital Markets Seminar
18th May 20172:49 pmRNSDirector/PDMR Shareholding
18th May 20179:41 amRNSDirector/PDMR Shareholding
18th May 20177:00 amRNSResults for the year to 31 March 2017
28th Apr 20173:05 pmRNSTotal Voting Rights
28th Apr 20173:05 pmRNSDirector/PDMR Shareholding
6th Apr 201711:37 amRNSPortfolio Update
6th Apr 201710:47 amRNSDirector Declaration
31st Mar 20171:50 pmRNSTotal Voting Rights
31st Mar 20171:50 pmRNSDirector/PDMR Shareholding
6th Mar 20179:45 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.